Tag: broadly neutralizing antibody
Bispecific Antibody 10E8.4/iMab Shows Promise in First Human Trial for HIV Prevention and Treatment
A phase 1 trial published in Nature Medicine shows that 10E8.4/iMab, a bispecific monoclonal antibody, is safe and well tolerated…
Submit Your Paper to GMJ
No APC until January 2027.